Skip to Content
Merck
  • MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells.

MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells.

Nature communications (2018-12-05)
Amir Bahat, Andres Goldman, Yehudit Zaltsman, Dilshad H Khan, Coral Halperin, Emmanuel Amzallag, Vladislav Krupalnik, Michael Mullokandov, Alon Silberman, Ayelet Erez, Aaron D Schimmer, Jacob H Hanna, Atan Gross
ABSTRACT

The role of mitochondria dynamics and its molecular regulators remains largely unknown during naïve-to-primed pluripotent cell interconversion. Here we report that mitochondrial MTCH2 is a regulator of mitochondrial fusion, essential for the naïve-to-primed interconversion of murine embryonic stem cells (ESCs). During this interconversion, wild-type ESCs elongate their mitochondria and slightly alter their glutamine utilization. In contrast, MTCH2-/- ESCs fail to elongate their mitochondria and to alter their metabolism, maintaining high levels of histone acetylation and expression of naïve pluripotency markers. Importantly, enforced mitochondria elongation by the pro-fusion protein Mitofusin (MFN) 2 or by a dominant negative form of the pro-fission protein dynamin-related protein (DRP) 1 is sufficient to drive the exit from naïve pluripotency of both MTCH2-/- and wild-type ESCs. Taken together, our data indicate that mitochondria elongation, governed by MTCH2, plays a critical role and constitutes an early driving force in the naïve-to-primed pluripotency interconversion of murine ESCs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Ethylmorpholine, BioXtra, suitable for protein sequencing, ≥99.5% (GC)
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Monoclonal Anti-MFN2 antibody produced in mouse, clone 4H8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-acetyl-Histone H3 Antibody, from rabbit